Maxcyte (MXCT) Net Shares Issued and Repurchased (2020 - 2025)

Maxcyte (MXCT) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 22.92% year-over-year to $2.6 million in Q4 2025; TTM through Dec 2025 was $2.6 million, a 22.92% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 22.92% from the prior year.
• Net Shares Issued and Repurchased was $2.6 million for Q4 2025 at Maxcyte, up from $2.1 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $4.4 million in Q4 2022 and troughed at $237200.0 in Q1 2022.
• A 5-year average of $2.7 million and a median of $2.6 million in 2023 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased slumped 38.45% in 2023 and climbed 22.92% in 2025, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.1 million in 2021, then grew by 7.05% to $4.4 million in 2022, then slumped by 38.45% to $2.7 million in 2023, then slipped by 22.83% to $2.1 million in 2024, then rose by 22.92% to $2.6 million in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $2.6 million (Q4 2025), $2.1 million (Q4 2024), and $2.7 million (Q4 2023), per Business Quant data.